Oragenics, Inc. (OGEN) Financials

OGEN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 7.5 million 1.3 million
Dec. 31, 2025 10.1 million 1.8 million
Sept. 30, 2025 12.7 million 2.9 million
June 30, 2025 2.1 million 4.3 million

OGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -2.2 million 17386
Dec. 31, 2025 -2.8 million 642.2 million
Sept. 30, 2025 -3.0 million 92510
June 30, 2025 -1.3 million 6632

OGEN Net Income

No data available :(

OGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.1 million - -
Dec. 31, 2025 8.4 million - -
Sept. 30, 2025 11.4 million - -
June 30, 2025 2.0 million - -

OGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.3 million
Dec. 31, 2025 4.3 million
Sept. 30, 2025 15609
June 30, 2025 7318

OGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4 645470 1.6 million -
Dec. 31, 2025 2 670543 1.8 million -
Sept. 30, 2025 5 930894 2.2 million -
June 30, 2025 - 449679 1.3 million -

OGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - 449679

OGEN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

OGEN

Price: $0.62

52 week price:
0.50
5.24

Earnings Per Share: -4.95 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23200

Market Capitalization: 2.8 million

Links: